Jacobs Levy Equity Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.8M | Buy |
2,397,739
+1,231,016
| +106% | +$14.3M | 0.11% | 177 |
|
|
2025
Q1 | $10.2M | Buy |
1,166,723
+1,135,356
| +3,620% | +$9.91M | 0.04% | 336 |
|
|
2024
Q4 | $450K | Buy |
+31,367
| New | +$450K | ﹤0.01% | 825 |
|
|
2024
Q3 | – | Sell |
-101,301
| Closed | -$1.97M | – | 1052 |
|
|
2024
Q2 | $1.97M | Buy |
101,301
+4,129
| +4% | +$80.3K | 0.01% | 597 |
|
|
2024
Q1 | $3.65M | Buy |
+97,172
| New | +$3.65M | 0.02% | 486 |
|